Tag Archives: dabigatran

Pradaxa Is Effective in All Types of Atrial Fibrillation

A new subgroup analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial Treatment indicated that the 150mg twice daily dose of dabigatran (Pradaxa) is equally safe and effective in patients with permanent, persistent, and paroxysmal atrial fibrillation.  Dabigatran … Continue reading

Posted in Arrhythmia, Cardiovascular disease | Tagged , , , , , , | Comments Off on Pradaxa Is Effective in All Types of Atrial Fibrillation

The Who, When, How to Take and Store PRADAXA (dabigatran)

What is PRADAXA? PRADAXA is a medicine used to prevent stroke and blood clots in people who have a atrial fibrillation.  How to take PRADAXA? PRADAXA should be taken orally, twice daily, with or without food.  Swallow PRADAXA capsules whole. … Continue reading

Posted in Arrhythmia, Cardiovascular disease, Stroke | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off on The Who, When, How to Take and Store PRADAXA (dabigatran)

New Drug to Prevent Future Strokes

As we all knew, patients who have a stroke or a transient ischemic attack have more than double the risk of having another attack. Now a subanalysis of RE-LY study which was published in The Lancet Neurology indicated that dabigatran … Continue reading

Posted in Cardiovascular disease, Stroke | Tagged , , , , , , | Comments Off on New Drug to Prevent Future Strokes

Another New Anticoagulant, Apixaban, Shown to Provide Stroke Reduction Benefit in Patients with Atrial Fibrillation:AVEROSE

The Apixaban versus Acetylsalicylic Acid to Prevent Strokes (AVERROES) trial, a study that compared the safety and effectiveness of apixaban (Pfizer/Bristol-Myers Squibb) and aspirin in patients with atrial fibrillation, has been stopped early after a predefined interim analysis by the … Continue reading

Posted in Cardiovascular disease, Stroke | Tagged , , , , , , | Comments Off on Another New Anticoagulant, Apixaban, Shown to Provide Stroke Reduction Benefit in Patients with Atrial Fibrillation:AVEROSE

Pradaxa is as Effective as Lovenox in Preventing VTE-event in Patients Setting Undergoing Hip Surgery: RE-NOVATE 2 study

In a randomized trial that was reported at the 2010 Congress of the European Hematology Association (EHA), the oral anticoagulant dabigatran (Pradaxa, Boehringer Ingelheim) was found to be as effective as subcutaneous enoxaparin (Lovenox, Sanofi-Aventis) in preventing venous thromboembolism (VTE) … Continue reading

Posted in Arrhythmia, Cardiovascular disease, Heart attack, Stroke, VTE | Tagged , , , , , , , , | 1 Comment

Which Herbal and Non-Herbal Supplements Interact with Warfarin?

The safety of warfarin use can be compromised by many popular herbal and nonherbal supplements taken by individuals.  Eight of the 10 most widely used supplements interact with warfarin, and many of these were associated with significant changes in the international … Continue reading

Posted in Cardiovascular disease, Herbal Medicine | Tagged , , , , , , , , , , , , , , , , , , | 2 Comments

Pradaxa eliminates the need to monitor INR in Atrial Fibrillation patients

Good news for atrial fibrillation (AF) patients who require taking warfarin to prevent stroke.  It is well known that routine blood monitor and food interaction represent major hassles for patients taking warfrin. However, a new drug, Pradaxa (dabigatran), might be … Continue reading

Posted in Arrhythmia, Cardiovascular disease | Tagged , , , , | Comments Off on Pradaxa eliminates the need to monitor INR in Atrial Fibrillation patients